| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Progesterone | 118 | 2024 | 865 | 9.390 |
Why?
|
| Uterus | 102 | 2023 | 594 | 9.210 |
Why?
|
| Progesterone | 91 | 2024 | 624 | 7.760 |
Why?
|
| Endometrium | 42 | 2024 | 276 | 5.910 |
Why?
|
| Embryo Implantation | 52 | 2023 | 230 | 5.660 |
Why?
|
| Mammary Glands, Animal | 42 | 2019 | 482 | 4.480 |
Why?
|
| Decidua | 31 | 2024 | 136 | 4.080 |
Why?
|
| RANK Ligand | 11 | 2022 | 49 | 3.310 |
Why?
|
| Nuclear Receptor Coactivator 2 | 13 | 2023 | 201 | 3.000 |
Why?
|
| Mice | 220 | 2024 | 17430 | 2.970 |
Why?
|
| Stromal Cells | 27 | 2024 | 294 | 2.910 |
Why?
|
| Epithelial Cells | 39 | 2024 | 900 | 2.690 |
Why?
|
| Animals | 238 | 2024 | 33618 | 2.360 |
Why?
|
| Morphogenesis | 15 | 2018 | 212 | 2.190 |
Why?
|
| beta Catenin | 12 | 2024 | 205 | 2.170 |
Why?
|
| Mice, Knockout | 110 | 2024 | 3710 | 2.110 |
Why?
|
| Doxycycline | 6 | 2024 | 117 | 2.050 |
Why?
|
| Transcriptome | 12 | 2022 | 907 | 1.800 |
Why?
|
| Mice, Transgenic | 48 | 2024 | 2391 | 1.770 |
Why?
|
| Endometrial Neoplasms | 15 | 2023 | 99 | 1.760 |
Why?
|
| Signal Transduction | 61 | 2023 | 4503 | 1.660 |
Why?
|
| Pregnancy | 80 | 2024 | 7105 | 1.580 |
Why?
|
| Early Growth Response Protein 1 | 3 | 2022 | 38 | 1.570 |
Why?
|
| Female | 224 | 2024 | 65117 | 1.570 |
Why?
|
| Estrogens | 23 | 2024 | 507 | 1.540 |
Why?
|
| Endometriosis | 10 | 2024 | 185 | 1.490 |
Why?
|
| Fertility | 19 | 2022 | 261 | 1.450 |
Why?
|
| Transcription Factors | 16 | 2024 | 2575 | 1.440 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 3 | 2019 | 12 | 1.380 |
Why?
|
| Gene Expression Regulation | 30 | 2021 | 2528 | 1.330 |
Why?
|
| CRISPR-Cas Systems | 3 | 2023 | 250 | 1.260 |
Why?
|
| Transcription, Genetic | 13 | 2020 | 1695 | 1.240 |
Why?
|
| Reproduction | 11 | 2024 | 237 | 1.170 |
Why?
|
| Cell Proliferation | 33 | 2024 | 2306 | 1.140 |
Why?
|
| Salivary Gland Neoplasms | 2 | 2019 | 55 | 1.130 |
Why?
|
| Epithelium | 23 | 2023 | 366 | 1.100 |
Why?
|
| Estrogen Receptor alpha | 18 | 2023 | 449 | 1.080 |
Why?
|
| Ovary | 20 | 2024 | 389 | 1.070 |
Why?
|
| Gene Expression Regulation, Developmental | 16 | 2021 | 996 | 1.040 |
Why?
|
| Pregnancy, Animal | 5 | 2017 | 73 | 1.040 |
Why?
|
| Estradiol | 24 | 2023 | 534 | 1.020 |
Why?
|
| PTEN Phosphohydrolase | 10 | 2020 | 269 | 1.010 |
Why?
|
| Progestins | 7 | 2016 | 47 | 0.980 |
Why?
|
| Mice, Inbred C57BL | 51 | 2021 | 4323 | 0.970 |
Why?
|
| Mammary Glands, Human | 4 | 2007 | 79 | 0.950 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 359 | 0.940 |
Why?
|
| Epidermis | 1 | 2024 | 60 | 0.930 |
Why?
|
| Keratinocytes | 1 | 2024 | 59 | 0.930 |
Why?
|
| Infertility, Female | 15 | 2018 | 165 | 0.900 |
Why?
|
| Mammary Neoplasms, Experimental | 6 | 2022 | 243 | 0.870 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2020 | 1872 | 0.850 |
Why?
|
| Breast Neoplasms | 11 | 2020 | 2478 | 0.820 |
Why?
|
| Mammary Neoplasms, Animal | 4 | 2010 | 137 | 0.770 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2017 | 906 | 0.770 |
Why?
|
| Neoplasm Proteins | 3 | 2024 | 669 | 0.760 |
Why?
|
| Genetic Engineering | 4 | 2018 | 161 | 0.750 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 3 | 2022 | 14 | 0.730 |
Why?
|
| Membrane Proteins | 8 | 2018 | 1523 | 0.730 |
Why?
|
| Repressor Proteins | 6 | 2020 | 811 | 0.720 |
Why?
|
| Leukemia | 1 | 2024 | 376 | 0.720 |
Why?
|
| Ovulation | 10 | 2022 | 112 | 0.690 |
Why?
|
| Integrases | 7 | 2024 | 161 | 0.680 |
Why?
|
| Infertility | 2 | 2018 | 90 | 0.670 |
Why?
|
| Nuclear Receptor Coactivators | 3 | 2015 | 72 | 0.670 |
Why?
|
| Salivary Glands | 1 | 2019 | 32 | 0.660 |
Why?
|
| Cell Differentiation | 21 | 2020 | 1915 | 0.640 |
Why?
|
| Breast | 5 | 2020 | 214 | 0.590 |
Why?
|
| Genes, Reporter | 3 | 2017 | 381 | 0.580 |
Why?
|
| Humans | 94 | 2024 | 122633 | 0.580 |
Why?
|
| Carcinogenesis | 6 | 2023 | 328 | 0.550 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2022 | 552 | 0.540 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 84 | 0.540 |
Why?
|
| Mifepristone | 10 | 2023 | 137 | 0.530 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2016 | 110 | 0.530 |
Why?
|
| Immunohistochemistry | 20 | 2016 | 1684 | 0.530 |
Why?
|
| Uterine Diseases | 3 | 2014 | 34 | 0.530 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 3 | 2022 | 57 | 0.520 |
Why?
|
| Models, Animal | 6 | 2024 | 463 | 0.510 |
Why?
|
| Fallopian Tubes | 4 | 2024 | 72 | 0.510 |
Why?
|
| Cells, Cultured | 15 | 2020 | 3047 | 0.500 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 1267 | 0.500 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2014 | 619 | 0.500 |
Why?
|
| Gene Expression Profiling | 10 | 2021 | 1670 | 0.490 |
Why?
|
| Wnt Proteins | 9 | 2017 | 198 | 0.470 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 377 | 0.460 |
Why?
|
| Receptors, Steroid | 6 | 2024 | 268 | 0.460 |
Why?
|
| Receptors, Estrogen | 8 | 2022 | 789 | 0.450 |
Why?
|
| Keratin-5 | 2 | 2024 | 6 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2020 | 491 | 0.450 |
Why?
|
| Gene Deletion | 15 | 2022 | 793 | 0.450 |
Why?
|
| DNA-Binding Proteins | 10 | 2021 | 2047 | 0.430 |
Why?
|
| Cell Division | 13 | 2011 | 778 | 0.410 |
Why?
|
| Cell Movement | 4 | 2022 | 831 | 0.410 |
Why?
|
| Protein Isoforms | 10 | 2022 | 408 | 0.400 |
Why?
|
| Promoter Regions, Genetic | 11 | 2020 | 1334 | 0.400 |
Why?
|
| Gene Expression | 13 | 2020 | 1568 | 0.400 |
Why?
|
| Disease Models, Animal | 14 | 2022 | 4257 | 0.400 |
Why?
|
| Forkhead Box Protein O1 | 4 | 2020 | 95 | 0.400 |
Why?
|
| Cell Nucleus | 3 | 2018 | 674 | 0.390 |
Why?
|
| Abortion, Spontaneous | 3 | 2021 | 85 | 0.390 |
Why?
|
| Stem Cells | 5 | 2023 | 701 | 0.390 |
Why?
|
| Sexual Behavior, Animal | 9 | 2006 | 87 | 0.390 |
Why?
|
| Models, Biological | 12 | 2020 | 1434 | 0.380 |
Why?
|
| Endometrial Hyperplasia | 5 | 2019 | 18 | 0.380 |
Why?
|
| Precancerous Conditions | 3 | 2022 | 288 | 0.370 |
Why?
|
| Carcinoma, Endometrioid | 3 | 2016 | 15 | 0.370 |
Why?
|
| Urogenital Abnormalities | 3 | 2020 | 168 | 0.370 |
Why?
|
| Ovarian Neoplasms | 3 | 2020 | 406 | 0.360 |
Why?
|
| Mice, Mutant Strains | 11 | 2021 | 381 | 0.350 |
Why?
|
| Autophagy-Related Proteins | 2 | 2020 | 31 | 0.350 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2022 | 522 | 0.340 |
Why?
|
| Oviducts | 4 | 2024 | 329 | 0.340 |
Why?
|
| Luteinizing Hormone | 8 | 2020 | 119 | 0.330 |
Why?
|
| Embryonic Development | 4 | 2020 | 208 | 0.330 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2023 | 215 | 0.330 |
Why?
|
| Estrous Cycle | 4 | 2020 | 31 | 0.330 |
Why?
|
| Transforming Growth Factor beta | 4 | 2020 | 456 | 0.320 |
Why?
|
| GATA2 Transcription Factor | 4 | 2018 | 45 | 0.320 |
Why?
|
| Models, Genetic | 4 | 2010 | 743 | 0.320 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2010 | 345 | 0.320 |
Why?
|
| Autophagy | 3 | 2023 | 390 | 0.310 |
Why?
|
| Paracrine Communication | 6 | 2013 | 71 | 0.310 |
Why?
|
| Gene Targeting | 4 | 2016 | 179 | 0.310 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2021 | 338 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 9 | 2019 | 1002 | 0.300 |
Why?
|
| beta-Galactosidase | 3 | 2011 | 143 | 0.300 |
Why?
|
| Hedgehog Proteins | 8 | 2018 | 192 | 0.300 |
Why?
|
| Trans-Activators | 6 | 2023 | 798 | 0.300 |
Why?
|
| Cell Line, Tumor | 11 | 2022 | 3283 | 0.290 |
Why?
|
| Wnt Signaling Pathway | 5 | 2021 | 195 | 0.290 |
Why?
|
| Tetracycline | 1 | 2007 | 78 | 0.290 |
Why?
|
| Ovariectomy | 15 | 2013 | 181 | 0.280 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2019 | 122 | 0.280 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2017 | 107 | 0.280 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2006 | 93 | 0.270 |
Why?
|
| Cervix Uteri | 3 | 2016 | 70 | 0.270 |
Why?
|
| Embryo, Mammalian | 6 | 2022 | 452 | 0.270 |
Why?
|
| Ribonuclease III | 2 | 2020 | 87 | 0.270 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2020 | 118 | 0.260 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2016 | 467 | 0.260 |
Why?
|
| Carcinoma | 3 | 2020 | 277 | 0.260 |
Why?
|
| HMGB Proteins | 2 | 2018 | 9 | 0.260 |
Why?
|
| SOXF Transcription Factors | 2 | 2018 | 16 | 0.260 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2003 | 98 | 0.260 |
Why?
|
| Thymus Gland | 2 | 2022 | 97 | 0.260 |
Why?
|
| STAT5 Transcription Factor | 3 | 2017 | 89 | 0.250 |
Why?
|
| Cdh1 Proteins | 3 | 2014 | 10 | 0.250 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2021 | 651 | 0.250 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 996 | 0.250 |
Why?
|
| COUP Transcription Factor II | 5 | 2023 | 117 | 0.250 |
Why?
|
| Phenotype | 9 | 2022 | 4200 | 0.250 |
Why?
|
| Cell Lineage | 2 | 2006 | 341 | 0.250 |
Why?
|
| RNA, Messenger | 16 | 2023 | 2815 | 0.250 |
Why?
|
| Chromatin Immunoprecipitation | 5 | 2013 | 239 | 0.250 |
Why?
|
| Cell Line | 11 | 2020 | 2774 | 0.250 |
Why?
|
| Placenta | 5 | 2016 | 493 | 0.240 |
Why?
|
| Transcriptional Activation | 2 | 2019 | 481 | 0.240 |
Why?
|
| Myometrium | 3 | 2019 | 48 | 0.240 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 355 | 0.240 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 3 | 2018 | 28 | 0.240 |
Why?
|
| Apoptosis | 14 | 2016 | 1782 | 0.240 |
Why?
|
| Ovarian Follicle | 5 | 2020 | 119 | 0.240 |
Why?
|
| Disease Progression | 8 | 2021 | 2024 | 0.240 |
Why?
|
| Granulosa Cells | 7 | 2022 | 133 | 0.230 |
Why?
|
| RNA-Binding Proteins | 2 | 2021 | 568 | 0.230 |
Why?
|
| NF-kappa B | 3 | 2022 | 458 | 0.230 |
Why?
|
| Hair Follicle | 1 | 2024 | 33 | 0.230 |
Why?
|
| Cell Cycle Proteins | 3 | 2020 | 647 | 0.230 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2019 | 216 | 0.230 |
Why?
|
| Calcitonin | 1 | 2004 | 31 | 0.230 |
Why?
|
| Gene Knockout Techniques | 3 | 2020 | 126 | 0.220 |
Why?
|
| Corpus Luteum | 4 | 2017 | 25 | 0.220 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2017 | 1293 | 0.220 |
Why?
|
| Adipose Tissue, White | 1 | 2024 | 78 | 0.220 |
Why?
|
| Zinc Fingers | 1 | 2024 | 114 | 0.220 |
Why?
|
| Embryonic Stem Cells | 2 | 2018 | 172 | 0.220 |
Why?
|
| Vagina | 2 | 2016 | 202 | 0.220 |
Why?
|
| Ligands | 3 | 2022 | 533 | 0.220 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 350 | 0.220 |
Why?
|
| Forkhead Transcription Factors | 3 | 2022 | 370 | 0.220 |
Why?
|
| Male | 43 | 2024 | 59714 | 0.220 |
Why?
|
| Phosphorylation | 10 | 2020 | 1610 | 0.210 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 2 | 2020 | 11 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 713 | 0.210 |
Why?
|
| Versicans | 1 | 2022 | 12 | 0.210 |
Why?
|
| Agglutinins | 1 | 2022 | 6 | 0.210 |
Why?
|
| RNA Interference | 4 | 2020 | 496 | 0.210 |
Why?
|
| Alleles | 4 | 2023 | 1594 | 0.210 |
Why?
|
| Receptors, Leptin | 1 | 2022 | 42 | 0.200 |
Why?
|
| Exons | 3 | 2023 | 795 | 0.200 |
Why?
|
| Glycoproteins | 1 | 2024 | 369 | 0.200 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2021 | 21 | 0.200 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2021 | 156 | 0.190 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 21 | 0.190 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 256 | 0.190 |
Why?
|
| Chromatin | 2 | 2023 | 552 | 0.190 |
Why?
|
| Parturition | 3 | 2022 | 62 | 0.190 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2021 | 55 | 0.190 |
Why?
|
| RNA, Small Interfering | 4 | 2018 | 662 | 0.190 |
Why?
|
| Vaginal Neoplasms | 1 | 2021 | 14 | 0.190 |
Why?
|
| Placentation | 2 | 2012 | 53 | 0.190 |
Why?
|
| Uterine Contraction | 1 | 2021 | 28 | 0.190 |
Why?
|
| Receptors, Oxytocin | 1 | 2021 | 20 | 0.190 |
Why?
|
| TRPC Cation Channels | 1 | 2021 | 22 | 0.180 |
Why?
|
| Mutation | 11 | 2023 | 5771 | 0.180 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2020 | 10 | 0.180 |
Why?
|
| Root Caries | 1 | 2020 | 1 | 0.180 |
Why?
|
| Protein Phosphatase 2 | 1 | 2020 | 29 | 0.180 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2020 | 24 | 0.180 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 5 | 0.180 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 67 | 0.180 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2020 | 47 | 0.180 |
Why?
|
| Skin Diseases | 1 | 2021 | 122 | 0.180 |
Why?
|
| Gonadotrophs | 1 | 2020 | 2 | 0.170 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 293 | 0.170 |
Why?
|
| Pregnancy Complications | 2 | 2015 | 502 | 0.170 |
Why?
|
| Hormones | 1 | 2020 | 188 | 0.170 |
Why?
|
| Lactation | 2 | 2011 | 186 | 0.170 |
Why?
|
| Receptors, Androgen | 3 | 2016 | 409 | 0.170 |
Why?
|
| Bone and Bones | 2 | 2019 | 262 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 225 | 0.170 |
Why?
|
| Biomarkers, Tumor | 3 | 2016 | 1424 | 0.160 |
Why?
|
| MicroRNAs | 5 | 2021 | 831 | 0.160 |
Why?
|
| Homozygote | 6 | 2012 | 531 | 0.160 |
Why?
|
| Energy Metabolism | 1 | 2024 | 740 | 0.160 |
Why?
|
| Premature Birth | 2 | 2014 | 379 | 0.160 |
Why?
|
| Cell Adhesion | 2 | 2017 | 321 | 0.160 |
Why?
|
| Hindlimb | 1 | 2019 | 75 | 0.160 |
Why?
|
| Fetal Development | 2 | 2022 | 111 | 0.160 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2019 | 77 | 0.160 |
Why?
|
| Aldose-Ketose Isomerases | 1 | 2018 | 11 | 0.160 |
Why?
|
| Homeostasis | 3 | 2020 | 679 | 0.160 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 44 | 0.160 |
Why?
|
| Body Patterning | 1 | 2019 | 122 | 0.160 |
Why?
|
| Bone Morphogenetic Protein 2 | 3 | 2014 | 84 | 0.160 |
Why?
|
| Microscopy, Fluorescence | 3 | 2020 | 330 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 3 | 2016 | 240 | 0.160 |
Why?
|
| Homeodomain Proteins | 3 | 2012 | 544 | 0.150 |
Why?
|
| Computational Biology | 2 | 2018 | 794 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2018 | 28 | 0.150 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 267 | 0.150 |
Why?
|
| Blotting, Western | 5 | 2017 | 1102 | 0.150 |
Why?
|
| Genitalia, Female | 2 | 2015 | 48 | 0.150 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 353 | 0.150 |
Why?
|
| Fetal Growth Retardation | 3 | 2015 | 221 | 0.150 |
Why?
|
| Macrophages | 3 | 2020 | 607 | 0.150 |
Why?
|
| Prostate | 2 | 2016 | 421 | 0.150 |
Why?
|
| Tamoxifen | 2 | 2017 | 363 | 0.150 |
Why?
|
| Corpus Luteum Maintenance | 1 | 2017 | 3 | 0.150 |
Why?
|
| Carbon Isotopes | 2 | 2018 | 271 | 0.150 |
Why?
|
| Luteal Cells | 1 | 2017 | 9 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 22 | 0.140 |
Why?
|
| Luminescence | 1 | 2017 | 15 | 0.140 |
Why?
|
| Janus Kinase 1 | 1 | 2017 | 14 | 0.140 |
Why?
|
| Protein Binding | 7 | 2017 | 1736 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2017 | 44 | 0.140 |
Why?
|
| Crosses, Genetic | 4 | 2014 | 155 | 0.140 |
Why?
|
| Cyclins | 1 | 1997 | 101 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2015 | 131 | 0.140 |
Why?
|
| Lactoferrin | 2 | 2000 | 77 | 0.140 |
Why?
|
| Mammals | 3 | 2022 | 262 | 0.140 |
Why?
|
| Catecholamines | 1 | 2017 | 56 | 0.140 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2017 | 106 | 0.140 |
Why?
|
| Oncogene Proteins | 1 | 1997 | 137 | 0.140 |
Why?
|
| Isoproterenol | 1 | 2017 | 105 | 0.140 |
Why?
|
| GATA Transcription Factors | 1 | 2016 | 8 | 0.140 |
Why?
|
| Cytokines | 1 | 2022 | 1280 | 0.140 |
Why?
|
| Kisspeptins | 1 | 2016 | 3 | 0.140 |
Why?
|
| src-Family Kinases | 1 | 2017 | 91 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 3 | 2017 | 602 | 0.130 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 222 | 0.130 |
Why?
|
| Junctional Adhesion Molecule B | 1 | 2016 | 2 | 0.130 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2016 | 8 | 0.130 |
Why?
|
| Prolactin | 6 | 2017 | 103 | 0.130 |
Why?
|
| Neurons | 5 | 2016 | 1926 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2017 | 153 | 0.130 |
Why?
|
| Animals, Newborn | 4 | 2015 | 988 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 376 | 0.130 |
Why?
|
| GATA6 Transcription Factor | 1 | 2015 | 10 | 0.130 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2015 | 31 | 0.130 |
Why?
|
| RNA Splicing Factors | 1 | 2016 | 49 | 0.130 |
Why?
|
| Luteinization | 1 | 2015 | 10 | 0.130 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 136 | 0.130 |
Why?
|
| Menstruation | 1 | 2015 | 28 | 0.130 |
Why?
|
| GATA4 Transcription Factor | 1 | 2015 | 40 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2019 | 281 | 0.130 |
Why?
|
| Estrogen Receptor beta | 1 | 2015 | 78 | 0.120 |
Why?
|
| Placental Insufficiency | 1 | 2015 | 13 | 0.120 |
Why?
|
| alpha-Galactosidase | 1 | 2014 | 20 | 0.120 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1996 | 71 | 0.120 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2015 | 63 | 0.120 |
Why?
|
| Fabry Disease | 1 | 2014 | 17 | 0.120 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 34 | 0.120 |
Why?
|
| Metaplasia | 1 | 2016 | 216 | 0.120 |
Why?
|
| p21-Activated Kinases | 1 | 2015 | 58 | 0.120 |
Why?
|
| Membrane Glycoproteins | 2 | 2016 | 414 | 0.120 |
Why?
|
| Germ Cells | 1 | 2016 | 192 | 0.120 |
Why?
|
| Microarray Analysis | 2 | 2013 | 230 | 0.120 |
Why?
|
| Receptor, Notch1 | 2 | 2013 | 66 | 0.120 |
Why?
|
| Vaginosis, Bacterial | 1 | 2014 | 19 | 0.120 |
Why?
|
| Cell Communication | 3 | 2011 | 165 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2014 | 239 | 0.120 |
Why?
|
| Neuropeptides | 1 | 2015 | 112 | 0.120 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 14 | 0.120 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2014 | 12 | 0.120 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 136 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 2 | 2013 | 211 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2013 | 414 | 0.110 |
Why?
|
| Metabolic Flux Analysis | 1 | 2013 | 12 | 0.110 |
Why?
|
| Seminiferous Tubules | 1 | 2013 | 14 | 0.110 |
Why?
|
| Serine | 1 | 2014 | 174 | 0.110 |
Why?
|
| Ovarian Diseases | 1 | 2014 | 28 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2012 | 242 | 0.110 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 194 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2014 | 35 | 0.110 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2014 | 35 | 0.110 |
Why?
|
| Hyaluronic Acid | 1 | 2014 | 95 | 0.110 |
Why?
|
| Inflammasomes | 1 | 2015 | 149 | 0.110 |
Why?
|
| Phosphofructokinase-2 | 1 | 2013 | 24 | 0.110 |
Why?
|
| Pituitary Gland | 3 | 2020 | 84 | 0.110 |
Why?
|
| Activin Receptors, Type I | 1 | 2013 | 33 | 0.110 |
Why?
|
| Adenomyosis | 1 | 2013 | 10 | 0.110 |
Why?
|
| Isotope Labeling | 1 | 2013 | 102 | 0.110 |
Why?
|
| Multigene Family | 1 | 2014 | 298 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2015 | 272 | 0.110 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2020 | 124 | 0.110 |
Why?
|
| Pregnancy Maintenance | 1 | 2013 | 5 | 0.110 |
Why?
|
| Medroxyprogesterone Acetate | 2 | 2013 | 18 | 0.110 |
Why?
|
| Phosphates | 1 | 2013 | 111 | 0.110 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2013 | 16 | 0.110 |
Why?
|
| Gonadotropin-Releasing Hormone | 4 | 2016 | 88 | 0.110 |
Why?
|
| Pseudopregnancy | 5 | 2012 | 17 | 0.110 |
Why?
|
| Follicle Stimulating Hormone | 4 | 2020 | 185 | 0.100 |
Why?
|
| Biomarkers | 2 | 2021 | 2935 | 0.100 |
Why?
|
| Cell Death | 4 | 2019 | 242 | 0.100 |
Why?
|
| ErbB Receptors | 1 | 2014 | 284 | 0.100 |
Why?
|
| Testis | 2 | 2013 | 405 | 0.100 |
Why?
|
| Nodal Protein | 1 | 2012 | 14 | 0.100 |
Why?
|
| Base Sequence | 7 | 2016 | 3093 | 0.100 |
Why?
|
| Receptors, Notch | 1 | 2014 | 202 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2016 | 1021 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 396 | 0.100 |
Why?
|
| Posture | 5 | 2006 | 153 | 0.100 |
Why?
|
| Cellular Reprogramming | 1 | 2013 | 116 | 0.100 |
Why?
|
| MSX1 Transcription Factor | 1 | 2011 | 15 | 0.100 |
Why?
|
| Uterine Neoplasms | 1 | 2013 | 118 | 0.100 |
Why?
|
| Recombination, Genetic | 4 | 2011 | 441 | 0.100 |
Why?
|
| Spermatogenesis | 1 | 2013 | 166 | 0.100 |
Why?
|
| Behavior, Animal | 2 | 2006 | 476 | 0.100 |
Why?
|
| Tuberous Sclerosis | 1 | 2013 | 121 | 0.100 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1992 | 84 | 0.100 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2011 | 19 | 0.100 |
Why?
|
| Inflammation | 2 | 2020 | 1398 | 0.100 |
Why?
|
| Cell Cycle | 3 | 2010 | 611 | 0.100 |
Why?
|
| Steroids | 2 | 2024 | 203 | 0.090 |
Why?
|
| Up-Regulation | 3 | 2020 | 867 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2013 | 383 | 0.090 |
Why?
|
| Aging | 3 | 2010 | 1164 | 0.090 |
Why?
|
| Heterozygote | 4 | 2012 | 671 | 0.090 |
Why?
|
| Spermatozoa | 1 | 2013 | 231 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 216 | 0.090 |
Why?
|
| Mullerian Ducts | 1 | 2011 | 40 | 0.090 |
Why?
|
| Frizzled Receptors | 1 | 2010 | 16 | 0.090 |
Why?
|
| Mesoderm | 1 | 2011 | 114 | 0.090 |
Why?
|
| In Situ Hybridization | 6 | 2010 | 473 | 0.090 |
Why?
|
| Polycomb Repressive Complex 2 | 2 | 2022 | 28 | 0.090 |
Why?
|
| Chorionic Gonadotropin | 2 | 2015 | 83 | 0.090 |
Why?
|
| Intestines | 1 | 2014 | 571 | 0.090 |
Why?
|
| Wnt4 Protein | 3 | 2017 | 20 | 0.090 |
Why?
|
| Dopamine | 4 | 2006 | 275 | 0.090 |
Why?
|
| Time Factors | 7 | 2017 | 6188 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 234 | 0.090 |
Why?
|
| Cyclooxygenase 2 | 4 | 2020 | 158 | 0.090 |
Why?
|
| Mice, 129 Strain | 3 | 2017 | 98 | 0.090 |
Why?
|
| Stem Cell Niche | 1 | 2010 | 54 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2020 | 144 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2015 | 555 | 0.090 |
Why?
|
| Endopeptidases | 2 | 2000 | 115 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2014 | 442 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2012 | 515 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 1 | 2011 | 154 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 428 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 712 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 964 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2007 | 108 | 0.080 |
Why?
|
| Transgenes | 2 | 2007 | 325 | 0.080 |
Why?
|
| Cell Membrane | 2 | 2009 | 459 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 6 | 2009 | 1584 | 0.080 |
Why?
|
| Genes, ras | 1 | 2009 | 96 | 0.080 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 122 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 2 | 2024 | 391 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 1015 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 317 | 0.080 |
Why?
|
| Sexual Maturation | 2 | 2013 | 48 | 0.080 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2008 | 11 | 0.080 |
Why?
|
| Down-Regulation | 4 | 2017 | 697 | 0.080 |
Why?
|
| DNA Primers | 2 | 2006 | 661 | 0.080 |
Why?
|
| Protein Transport | 2 | 2006 | 368 | 0.080 |
Why?
|
| Gap Junctions | 1 | 2008 | 35 | 0.080 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 117 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinase | 2 | 2020 | 26 | 0.080 |
Why?
|
| Organ Specificity | 3 | 2016 | 423 | 0.080 |
Why?
|
| Metabolome | 3 | 2018 | 293 | 0.070 |
Why?
|
| Neuroglia | 1 | 2009 | 193 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2009 | 293 | 0.070 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 30 | 0.070 |
Why?
|
| Bone Development | 1 | 2008 | 56 | 0.070 |
Why?
|
| Kidney | 1 | 2014 | 1337 | 0.070 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 1577 | 0.070 |
Why?
|
| Mice, Inbred Strains | 3 | 2004 | 308 | 0.070 |
Why?
|
| Papillomavirus E7 Proteins | 2 | 2020 | 19 | 0.070 |
Why?
|
| Bone Remodeling | 1 | 2008 | 54 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2008 | 91 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1513 | 0.070 |
Why?
|
| Gene Components | 1 | 2006 | 7 | 0.070 |
Why?
|
| Transfection | 5 | 2017 | 1068 | 0.070 |
Why?
|
| Organogenesis | 2 | 2018 | 77 | 0.070 |
Why?
|
| Neoplasms, Experimental | 2 | 2020 | 211 | 0.070 |
Why?
|
| Milk Proteins | 2 | 2007 | 91 | 0.070 |
Why?
|
| Desoxycorticosterone | 1 | 2006 | 14 | 0.070 |
Why?
|
| Trophoblasts | 2 | 2020 | 112 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 318 | 0.070 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 52 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 260 | 0.070 |
Why?
|
| Substantia Nigra | 1 | 2006 | 33 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 281 | 0.070 |
Why?
|
| Ventral Tegmental Area | 1 | 2006 | 50 | 0.060 |
Why?
|
| Chloride Channels | 1 | 2006 | 62 | 0.060 |
Why?
|
| Leukemia Inhibitory Factor | 2 | 2018 | 26 | 0.060 |
Why?
|
| Glycolysis | 2 | 2018 | 142 | 0.060 |
Why?
|
| Embryo Loss | 2 | 2017 | 26 | 0.060 |
Why?
|
| Sex Characteristics | 4 | 2006 | 309 | 0.060 |
Why?
|
| Blastocyst | 2 | 2015 | 76 | 0.060 |
Why?
|
| Phosphoproteins | 3 | 2016 | 399 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2021 | 876 | 0.060 |
Why?
|
| Gonadotropins | 2 | 2020 | 36 | 0.060 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2016 | 38 | 0.060 |
Why?
|
| Cell Polarity | 2 | 2018 | 125 | 0.060 |
Why?
|
| Lac Operon | 1 | 2005 | 94 | 0.060 |
Why?
|
| Genotype | 5 | 2014 | 2531 | 0.060 |
Why?
|
| Promegestone | 2 | 2016 | 30 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2005 | 102 | 0.060 |
Why?
|
| Serpins | 1 | 2004 | 27 | 0.060 |
Why?
|
| RNA | 2 | 2007 | 576 | 0.060 |
Why?
|
| Stroke | 1 | 2012 | 957 | 0.060 |
Why?
|
| Pregnancy Outcome | 2 | 2021 | 592 | 0.060 |
Why?
|
| Receptors, Calcitonin | 1 | 2004 | 21 | 0.060 |
Why?
|
| Gene Silencing | 2 | 2016 | 237 | 0.060 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2023 | 20 | 0.060 |
Why?
|
| Hypothalamus | 3 | 2000 | 214 | 0.060 |
Why?
|
| Disintegrins | 2 | 2000 | 11 | 0.060 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2023 | 23 | 0.060 |
Why?
|
| Cathepsins | 2 | 2000 | 21 | 0.060 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 2 | 2002 | 56 | 0.060 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2023 | 16 | 0.050 |
Why?
|
| Beclin-1 | 1 | 2023 | 27 | 0.050 |
Why?
|
| Chimera | 3 | 2006 | 88 | 0.050 |
Why?
|
| Adherens Junctions | 2 | 2013 | 12 | 0.050 |
Why?
|
| Metalloendopeptidases | 2 | 2000 | 101 | 0.050 |
Why?
|
| Rodentia | 1 | 2023 | 46 | 0.050 |
Why?
|
| Receptors, Prolactin | 1 | 2002 | 11 | 0.050 |
Why?
|
| DNA | 3 | 2003 | 1591 | 0.050 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2002 | 21 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2016 | 83 | 0.050 |
Why?
|
| Restriction Mapping | 1 | 2002 | 187 | 0.050 |
Why?
|
| Hyperplasia | 3 | 2001 | 210 | 0.050 |
Why?
|
| Dilatation | 1 | 2022 | 68 | 0.050 |
Why?
|
| Anxiety | 2 | 2006 | 953 | 0.050 |
Why?
|
| Horses | 1 | 2022 | 89 | 0.050 |
Why?
|
| Parity | 1 | 2002 | 79 | 0.050 |
Why?
|
| Tumor Microenvironment | 2 | 2017 | 538 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2002 | 173 | 0.050 |
Why?
|
| Molecular Chaperones | 2 | 2015 | 167 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2002 | 137 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2000 | 3870 | 0.050 |
Why?
|
| Receptor, ErbB-2 | 2 | 2015 | 495 | 0.050 |
Why?
|
| Arteries | 1 | 2022 | 222 | 0.050 |
Why?
|
| Binding Sites | 3 | 2012 | 1292 | 0.050 |
Why?
|
| Carotid Artery Injuries | 1 | 2001 | 39 | 0.050 |
Why?
|
| ADAMTS1 Protein | 3 | 2011 | 16 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2000 | 258 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2014 | 739 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2015 | 669 | 0.050 |
Why?
|
| Salpingo-oophorectomy | 1 | 2020 | 10 | 0.050 |
Why?
|
| Aggression | 1 | 2003 | 226 | 0.050 |
Why?
|
| Lim Kinases | 1 | 2020 | 9 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2020 | 17 | 0.050 |
Why?
|
| Insulin | 2 | 2002 | 1189 | 0.050 |
Why?
|
| ADAM Proteins | 3 | 2011 | 79 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2020 | 22 | 0.040 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2020 | 55 | 0.040 |
Why?
|
| Ectoderm | 1 | 2020 | 31 | 0.040 |
Why?
|
| Androgens | 2 | 2001 | 256 | 0.040 |
Why?
|
| Organ Size | 3 | 2008 | 411 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2014 | 966 | 0.040 |
Why?
|
| Pregnancy, Tubal | 1 | 2020 | 6 | 0.040 |
Why?
|
| Hormone Antagonists | 3 | 2008 | 63 | 0.040 |
Why?
|
| Pregnanolone | 2 | 2012 | 11 | 0.040 |
Why?
|
| Fibrosis | 1 | 2021 | 429 | 0.040 |
Why?
|
| Papillomaviridae | 1 | 2020 | 137 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 2014 | 469 | 0.040 |
Why?
|
| Sperm Count | 2 | 2013 | 75 | 0.040 |
Why?
|
| Radioimmunoassay | 3 | 2006 | 109 | 0.040 |
Why?
|
| Aquaporins | 1 | 2019 | 17 | 0.040 |
Why?
|
| Cell Survival | 2 | 2014 | 803 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2013 | 34 | 0.040 |
Why?
|
| Keratins | 1 | 2019 | 54 | 0.040 |
Why?
|
| Transplantation Tolerance | 1 | 2019 | 15 | 0.040 |
Why?
|
| Proteome | 1 | 2020 | 233 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2023 | 845 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 2 | 2014 | 65 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2013 | 1209 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 2395 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2017 | 893 | 0.040 |
Why?
|
| Proteins | 1 | 2004 | 1037 | 0.040 |
Why?
|
| Endothelium | 1 | 1999 | 71 | 0.040 |
Why?
|
| Skin | 1 | 2021 | 502 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2019 | 80 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2019 | 81 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 665 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 751 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 131 | 0.040 |
Why?
|
| Rats | 4 | 2013 | 3620 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 93 | 0.040 |
Why?
|
| Glucose | 1 | 2002 | 867 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2010 | 1115 | 0.040 |
Why?
|
| Anovulation | 1 | 1997 | 4 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 20 | 0.040 |
Why?
|
| Glossopharyngeal Nerve | 1 | 1997 | 7 | 0.040 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2017 | 12 | 0.040 |
Why?
|
| Ganglia | 1 | 1997 | 20 | 0.040 |
Why?
|
| EGF Family of Proteins | 1 | 2017 | 12 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 101 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 1997 | 113 | 0.040 |
Why?
|
| Receptors, OSM-LIF | 1 | 2017 | 7 | 0.040 |
Why?
|
| Histone Acetyltransferases | 2 | 2009 | 313 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2012 | 94 | 0.040 |
Why?
|
| Testosterone | 3 | 2013 | 462 | 0.040 |
Why?
|
| Aging, Premature | 1 | 2017 | 31 | 0.040 |
Why?
|
| Chemokines | 1 | 2017 | 137 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2012 | 137 | 0.030 |
Why?
|
| Hypothalamus, Anterior | 1 | 2016 | 1 | 0.030 |
Why?
|
| Consensus Sequence | 2 | 2012 | 58 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 678 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 230 | 0.030 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2016 | 40 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2016 | 49 | 0.030 |
Why?
|
| Chorion | 1 | 2016 | 8 | 0.030 |
Why?
|
| Endometritis | 1 | 1996 | 9 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2010 | 1003 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 575 | 0.030 |
Why?
|
| Immunologic Surveillance | 1 | 2015 | 15 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 1996 | 16 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2016 | 293 | 0.030 |
Why?
|
| Copulation | 1 | 1995 | 10 | 0.030 |
Why?
|
| Smad4 Protein | 1 | 2015 | 55 | 0.030 |
Why?
|
| Histones | 1 | 2019 | 528 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 348 | 0.030 |
Why?
|
| Cysts | 1 | 2016 | 100 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 412 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 46 | 0.030 |
Why?
|
| Placental Circulation | 1 | 2015 | 23 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 547 | 0.030 |
Why?
|
| Noise | 1 | 2015 | 19 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 160 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2014 | 49 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 150 | 0.030 |
Why?
|
| Receptor, ErbB-3 | 1 | 2014 | 16 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 33 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2014 | 35 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2001 | 769 | 0.030 |
Why?
|
| Arginase | 1 | 2014 | 28 | 0.030 |
Why?
|
| Axons | 1 | 1997 | 381 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 1063 | 0.030 |
Why?
|
| Oocytes | 1 | 2016 | 290 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 134 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2014 | 42 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 42 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 210 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 582 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1997 | 549 | 0.030 |
Why?
|
| Activins | 1 | 2013 | 74 | 0.030 |
Why?
|
| Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2013 | 5 | 0.030 |
Why?
|
| Tight Junction Proteins | 1 | 2013 | 12 | 0.030 |
Why?
|
| Aromatase | 1 | 2013 | 22 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2014 | 99 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 62 | 0.030 |
Why?
|
| Proteomics | 1 | 2017 | 477 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 44 | 0.030 |
Why?
|
| Angiopoietins | 1 | 2013 | 20 | 0.030 |
Why?
|
| Mucins | 1 | 2013 | 74 | 0.030 |
Why?
|
| Injections | 1 | 2013 | 152 | 0.030 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 2013 | 5 | 0.030 |
Why?
|
| Genes, APC | 1 | 2013 | 13 | 0.030 |
Why?
|
| Giant Cells | 1 | 2013 | 34 | 0.030 |
Why?
|
| Leydig Cells | 1 | 2013 | 20 | 0.030 |
Why?
|
| Levonorgestrel | 1 | 2013 | 20 | 0.030 |
Why?
|
| Injections, Subcutaneous | 2 | 2006 | 125 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 189 | 0.030 |
Why?
|
| Aromatase Inhibitors | 1 | 2013 | 75 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 324 | 0.030 |
Why?
|
| Sertoli Cells | 1 | 2013 | 75 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 462 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2013 | 124 | 0.030 |
Why?
|
| Norprogesterones | 1 | 2012 | 2 | 0.030 |
Why?
|
| alpha Catenin | 1 | 2012 | 6 | 0.030 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 16 | 0.030 |
Why?
|
| Leiomyoma | 1 | 2013 | 90 | 0.030 |
Why?
|
| Keratin-8 | 1 | 2012 | 11 | 0.030 |
Why?
|
| Occludin | 1 | 2012 | 18 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 253 | 0.030 |
Why?
|
| Neprilysin | 1 | 2012 | 19 | 0.030 |
Why?
|
| Interleukin-15 | 1 | 2013 | 93 | 0.030 |
Why?
|
| Motor Activity | 2 | 2006 | 511 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2013 | 175 | 0.030 |
Why?
|
| Claudins | 1 | 2012 | 29 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2012 | 123 | 0.030 |
Why?
|
| Choristoma | 1 | 2012 | 49 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2012 | 37 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2014 | 419 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 287 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1992 | 64 | 0.020 |
Why?
|
| Response Elements | 1 | 2012 | 97 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2012 | 392 | 0.020 |
Why?
|
| Wnt-5a Protein | 1 | 2011 | 22 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 354 | 0.020 |
Why?
|
| Fetal Death | 1 | 2012 | 112 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 227 | 0.020 |
Why?
|
| Sirolimus | 1 | 2013 | 219 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 144 | 0.020 |
Why?
|
| Gene Library | 1 | 1992 | 220 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 2011 | 70 | 0.020 |
Why?
|
| Cumulus Cells | 1 | 2011 | 43 | 0.020 |
Why?
|
| Levodopa | 1 | 1992 | 89 | 0.020 |
Why?
|
| Fetus | 1 | 2015 | 570 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2011 | 27 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 1003 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2011 | 47 | 0.020 |
Why?
|
| Cattle | 1 | 1992 | 559 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2011 | 35 | 0.020 |
Why?
|
| Ovalbumin | 1 | 1991 | 318 | 0.020 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2011 | 60 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 323 | 0.020 |
Why?
|
| Metabolomics | 1 | 2014 | 396 | 0.020 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2010 | 20 | 0.020 |
Why?
|
| Cathepsin L | 2 | 2000 | 11 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 2010 | 142 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 351 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2011 | 178 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2013 | 447 | 0.020 |
Why?
|
| Adult | 3 | 2020 | 28881 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 2 | 2000 | 49 | 0.020 |
Why?
|
| Smoothened Receptor | 1 | 2010 | 28 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2010 | 25 | 0.020 |
Why?
|
| Cysteine Endopeptidases | 2 | 2000 | 114 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 519 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 441 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 764 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2010 | 101 | 0.020 |
Why?
|
| Patched Receptors | 1 | 2009 | 26 | 0.020 |
Why?
|
| Genome | 1 | 2012 | 470 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 1683 | 0.020 |
Why?
|
| Patched-1 Receptor | 1 | 2009 | 33 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2009 | 84 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2009 | 138 | 0.020 |
Why?
|
| Swine | 1 | 1992 | 1154 | 0.020 |
Why?
|
| Mice, Nude | 2 | 2001 | 691 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1992 | 423 | 0.020 |
Why?
|
| DNA Replication | 2 | 2001 | 343 | 0.020 |
Why?
|
| Connexin 43 | 1 | 2008 | 30 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2015 | 991 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3256 | 0.020 |
Why?
|
| Epiphyses | 1 | 2008 | 6 | 0.020 |
Why?
|
| Diaphyses | 1 | 2008 | 5 | 0.020 |
Why?
|
| Humerus | 1 | 2008 | 14 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 22 | 0.020 |
Why?
|
| Nitrobenzenes | 1 | 2008 | 16 | 0.020 |
Why?
|
| Colforsin | 1 | 2008 | 48 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 69 | 0.020 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2007 | 8 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2008 | 76 | 0.020 |
Why?
|
| Trefoil Factor-1 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Litter Size | 1 | 2007 | 24 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2009 | 194 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2697 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 25849 | 0.020 |
Why?
|
| Anilides | 1 | 2008 | 48 | 0.020 |
Why?
|
| Indomethacin | 1 | 2008 | 84 | 0.020 |
Why?
|
| Embryo Implantation, Delayed | 1 | 2007 | 3 | 0.020 |
Why?
|
| Tibia | 1 | 2008 | 70 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2008 | 212 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 144 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2007 | 37 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2007 | 70 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 198 | 0.020 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2007 | 66 | 0.020 |
Why?
|
| Astrocytes | 1 | 2009 | 250 | 0.020 |
Why?
|
| Ovulation Induction | 1 | 2007 | 60 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3079 | 0.020 |
Why?
|
| Superovulation | 1 | 2006 | 12 | 0.020 |
Why?
|
| Electroporation | 1 | 2006 | 33 | 0.020 |
Why?
|
| Muscimol | 1 | 2006 | 9 | 0.020 |
Why?
|
| Genetics, Behavioral | 1 | 2006 | 9 | 0.020 |
Why?
|
| Receptors, GABA | 1 | 2006 | 14 | 0.020 |
Why?
|
| GABA Agonists | 1 | 2006 | 15 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 1758 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2008 | 258 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 252 | 0.020 |
Why?
|
| Dopamine Antagonists | 1 | 2006 | 50 | 0.020 |
Why?
|
| Brain | 2 | 2012 | 2942 | 0.020 |
Why?
|
| Gestational Age | 1 | 2009 | 1115 | 0.020 |
Why?
|
| Motor Skills | 1 | 2006 | 83 | 0.020 |
Why?
|
| Bone Density | 1 | 2008 | 309 | 0.020 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 1 | 2005 | 5 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 303 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 85 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2006 | 167 | 0.020 |
Why?
|
| Enzymes | 1 | 2005 | 51 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 4488 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2005 | 135 | 0.010 |
Why?
|
| Body Weight | 1 | 2008 | 959 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 202 | 0.010 |
Why?
|
| Castration | 1 | 2003 | 31 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 18987 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2002 | 8 | 0.010 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2002 | 19 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 2002 | 23 | 0.010 |
Why?
|
| Aldosterone | 1 | 2002 | 59 | 0.010 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2002 | 41 | 0.010 |
Why?
|
| Cell Size | 1 | 2002 | 81 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2002 | 78 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 262 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2002 | 155 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 248 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2002 | 214 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2002 | 149 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2002 | 203 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 2788 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 298 | 0.010 |
Why?
|
| Carotid Artery, Common | 1 | 2001 | 73 | 0.010 |
Why?
|
| Diabetes, Gestational | 1 | 2002 | 107 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 2000 | 23 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2002 | 218 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 88 | 0.010 |
Why?
|
| Hippocampus | 1 | 2006 | 810 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2000 | 223 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 462 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2000 | 103 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 8817 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 1242 | 0.010 |
Why?
|
| Autoradiography | 1 | 1998 | 71 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2002 | 1102 | 0.010 |
Why?
|
| Wnt2 Protein | 1 | 1997 | 3 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2002 | 634 | 0.010 |
Why?
|
| COUP Transcription Factor I | 1 | 1997 | 91 | 0.010 |
Why?
|
| Activating Transcription Factor 1 | 1 | 1997 | 4 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1997 | 118 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1997 | 120 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 1997 | 33 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1997 | 132 | 0.010 |
Why?
|
| Transplantation | 1 | 1997 | 28 | 0.010 |
Why?
|
| Rhombencephalon | 1 | 1997 | 45 | 0.010 |
Why?
|
| Neural Crest | 1 | 1997 | 51 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 1997 | 32 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1996 | 179 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1997 | 110 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 1390 | 0.010 |
Why?
|
| Introns | 1 | 1997 | 302 | 0.010 |
Why?
|
| Serotonin | 1 | 1996 | 222 | 0.010 |
Why?
|
| Ergolines | 1 | 1991 | 7 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 1991 | 14 | 0.010 |
Why?
|
| Ethers, Cyclic | 1 | 1991 | 14 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1991 | 24 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1991 | 79 | 0.010 |
Why?
|
| Chickens | 1 | 1991 | 636 | 0.010 |
Why?
|